arianna

best video: vaxgen

scarlet letter movie colonial era
shapely secrets
mew sapphire

The most popular links about vaxgen (by google opininon):

VaxGen sells anthrax vaccine to its old rival - FierceBioResearcher

Reduced to a skeleton crew and a bleak outlook, South San Francisco-based vaxgen sold its experimental anthrax vaccine to its former chief rival, ...
http://www.fiercebioresearcher.com/vaccines/story/vaxgen-sells-anthrax-vaccine-to-its-old-rival/2008-05-08

Catastrophic Setback: "The hopes of an AIDS vaccine are dashed"

The significance of the failure of more than 30 AIDS vaccine trials Link is finally being recognized by prominent mainstream scientists such as, Nobel-winner, Dr. David Baltimore, who acknowledged that the best hope" may lie in the biological equiv
http://ahrp.blogspot.com/2008/04/catastrophic-setback-hopes-of-aids.html

AFX UK Focus 2008-05-05 07:14 VaxGen sells anthrax vaccine candidate to Emergent BioSolutions Interactive Investor

SOUTH SAN FRANCISCO, CA Thomson Financial - Biopharmaceutical company vaxgen Inc. said it has completed the sale of all assets and rights related to its recombinant protective antigen rPA anthrax vaccine product candidate and related technology to Eme
http://www.iii.co.uk/news/?type=afxnews&articleid=6692245&subject=companies&action=article

Anthrax Vaccine Contract Voided, Thwarting Administration

Federal health officials yesterday scuttled the largest piece of the Bush administration's two-year program to counter bioterrorism, canceling an 877.5 million contract with vaxgen to develop an anthrax vaccine after the company missed a deadline to begi
http://www.washingtonpost.com/wp-dyn/content/article/2006/12/19/AR2006121901689.html?

Layoffs at VaxGen follow failed Raven merger - San Francisco ...

The two South San Francisco neighbors hoped to merge, but vaxgen OTCBB: VXGN ... Pfeffer, the outgoing CFO, had his employment agreement with vaxgen ...
http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2008/04/07/daily23.html

VaxGen - Wikipedia, the free encyclopedia

VaxGen is a biopharmaceutical company based in the San Francisco Bay Area . ...
http://en.wikipedia.org/wiki/Vaxgen

Pressroom ::: Next Generation Biodefense, Anthrax Vaccine, Smallpox ...

VaxGen, Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the ...
http://www.vaxgen.com/pressroom/index.html

Bon-Ton Stores Signs License And Design Deal With Victor Alfaro ... - RTT News

5/5/2008 12:36:07 AM vaxgen Inc. VXGN.OB announced that it has completed sale of all assets and rights related to its recombinant protective antigen or ...
http://www.rttnews.com/sp/Quickfactsnew.asp?date=05/05/2008&item=5

Are Biotech Companies Stymied In Dealing With Universities?

The San Francisco Business Journal ran a feature suggesting that biotech companies are running into hurdles in doing deals with universities, specifically the University of California System in this case. The article writes that the problem is that it si
http://www.patentbaristas.com/archives/2008/04/25/are-biotech-companies-stymied-in-dealing-with-universities/

Maryland's Emergent BioSolutions acquires VaxGen tech TechJournal South

ROCKVILLE, MD--Emergent BioSolutions Inc. NYSE: EBS has completed the acquisition of all assets and rights related to a recombinant protective antigen anthrax vaccine product candidate and related technology from vaxgen Inc.
http://www.techjournalsouth.com/news/article.html?item_id=5289

VaxGen, Inc

VaxGen, Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and ...
http://www.vaxgen.com/

VaxGen cuts workforce again

After having to cancel its planned merger last month, VaxGen, the South San Francisco company that lost a 877.5 million federal contract to develop an anthrax vaccine, said today ...
http://www.santacruzsentinel.com/ci_8865159

VaxGen Expands Its Board of Directors Eve Slater, a Former Merck ...

VXGN vaxgen Expands Its Board of Directors Eve Slater, a Former Merck Executive and HHS Official, and Kevin Reilly, a Former Wyeth E...
http://www.advfn.com/news_vaxgen-expands-its-board-of-directors--eve-slater--a-former-merck-executive-and-_11858675.html

Ross Stores sees jump in sales - Inside Bay Area

VaxGen, a South San Francisco biopharmaceutical company, announced that it has completed the sale of all assets and rights related to its anthrax vaccine ...
http://www.insidebayarea.com/ci_9194080

Who is Dr. William Heyward?

William Heyward, a man who was born in Atlanta Georgia, USA, studied in Johns Hopkins University School of Hygiene and Public Health in Baltimore, Maryland and got a degree of M.P.H. in Epidemiology, Medical College of Georgia, Augusta, Georgia, for his M
http://idealpinkrose.blogspot.com/2008/03/who-is-dr-william-heyward.html

Emergent acquires VaxGen rPA UPI

ROCKVILLE, Md., May 5 UPI -- Maryland-based Emergent BioSolutions says it has acquired VaxGen's recombinant protective antigen to increase its biological threats countermeasure offerings.
http://www.upi.com/International_Security/Industry/Briefing/2008/05/05/emergent_acquires_vaxgen_rpa/3711/

CIDRAP >> HHS cancels VaxGen anthrax vaccine contract

Dec 20, 2006 CIDRAP News ?? The US government yesterday canceled its 877.5 million contract with vaxgen Inc. for a new anthrax vaccine, after problems ...
http://www.cidrap.umn.edu/cidrap/content/bt/anthrax/news/dec2006vaxgen.html

CIDRAP &gt&gt FDA orders delay of anthrax vaccine trial

Nov 6, 2006 CIDRAP News ?? vaxgen Inc. ... The vaxgen anthrax vaccine is intended to ... Nov 4 vaxgen press release on cure notice for anthrax contract ...
http://www.cidrap.umn.edu/cidrap/content/bt/anthrax/news/nov0606anthrax.html

Infectious Disease Expert Joins VaxGen's Board of Directors

VXGN.PK Infectious Disease Expert Joins VaxGen's Board of Directors...
http://www.advfn.com/news_infectious-disease-expert-joins-vaxgen-s-board-of-directors_9146841.html

ALSO NOTED: User error hikes risk of insulin pumps in teens ... - FiercePharma

Discovery report > After spending 175 million in an unsuccessful effort to push a new anthrax vaccine into the clinic, vaxgen has sold the program to ...
http://www.fiercepharma.com/story/also-noted-user-error-hikes-risk-of-insulin-pumps-in-teens-pfizer-preps-new/2008-05-06

Dr. William Heyward's Press Release

William Heyward, M.D., M.P.H., is the renowned doctor who consistently fights against the world??s deadliest communicable diseases for almost three decades now. Traveled to remote places as far as Zaire, Alaska, South America and Thailand to focus on his
http://echathost.genblogger.com/23070

VaxGen sells anthrax vaccine to rival firm CIDRAP

May 7, 2008 CIDRAP News ?? vaxgen Inc. announced this week the sale of its experimental anthrax vaccine??which the US government pulled the plug on in 2006??to Emergent BioSolutions, maker of the only US-licensed anthrax vaccine.
http://www.cidrap.umn.edu/cidrap/content/bt/anthrax/news/may0708anthrax.html

VaxGen Sells Anthrax Vaccine Program and Related Assets and ...

May 7, 2008 ... SOUTH SAN FRANCISCO Calif. May 5 /- VaxGe...Logo: A HREF http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOG.
http://www.bio-medicine.org/biology-technology-1/VaxGen-Sells-Anthrax-Vaccine-Program-and-Related-Assets-and-Technology-to-Emergent-BioSolutions--Inc--5081-1/

VaxGen

Focused on the commercial development of biologic products for the prevention of and treatment of HIV/AIDS and other human infectious disease.
http://www.vaxgen.com/

VaxGen, Inc

VaxGen, Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the ...
http://www.vaxgen.com/

VaxGen sells anthrax vaccine to rival firm - CIDRAP

May 7, 2008 CIDRAP News ?? vaxgen Inc. announced this week the sale of its experimental anthrax vaccine??which the US government pulled the plug on in ...
http://www.cidrap.umn.edu/cidrap/content/bt/anthrax/news/may0708anthrax.html

Our Government Inaction

There's a great story buried in the Washington Post's Business section. Emergent BioSolutions, nee BioPort, bought out VaxGen's anthrax vaccine candidate that failed to reach FDA approval in 2006. Emergent has paid vaxgen 2 million up front and may pay..
http://armchairgeneralist.typepad.com/my_weblog/2008/05/our-government.html

More News Gazette.Net

The Rockville company this week reported a first-quarter profit of 7.0 million, versus a net loss of 2.7 million a year ago. Revenues grew to 42.7 million from 26.4 million, mostly from higher sales of its lead product, BioThrax.
http://www.gazette.net/stories/050908/businew183019_32365.shtml

VaxGen Wins Extension on Anthrax Vaccine - washingtonpost.com

VaxGen Inc., a California biotechnology firm, said yesterday that the government had given it more time to conduct human testing of its anthrax vaccine, ...
http://www.washingtonpost.com/wp-dyn/content/article/2006/11/16/AR2006111601522.html

VaxGen Restructures Following Termination of Proposed Merger : Rx ...

Rx Times - Pharmacy Magazine. Your Pharmacy Resource for news, jobs, continuing education, pharmacy products and services, and pharmacy discussion forum. ... SOUTH SAN FRANCISCO ...
http://www.rxtimes.com/?p=1222

BioPortfolio News : VaxGen Hires Henk Kocken, Ph.D. as Vice ...

BioPortfolio News - vaxgen Hires Henk Kocken, Ph.D. as Vice President for Quality Systems
http://www.bioportfolio.com/may_05/03_05_2005/VaxGen_Hires_Henk_Kocken_Ph_D.html

Matthew J. Pfeffer Joins MannKind as Corporate Vice President and ... - FOXBusiness

Mr. Pfeffer served as Chief Financial Officer and Senior Vice President of Finance and Administration of VaxGen, Inc. from March 2006 until April 2008, ...
http://www.foxbusiness.com/markets/industries/health-care/article/matthew-j-pfeffer-joins-mannkind-corporate-vice-president-chief-financial_566179_10.html

VaxGen, Raven Bio terminate merger agreement

See our story about these two South San Francisco, Calif., biotechs in today??s daily briefing at VentureBeat LifeScience.
http://venturebeat.com/2008/03/28/vaxgen-raven-bio-terminate-merger-agreement/

Emergent buys rival VaxGen vaccine Lansing State Journal

Emergent BioSolutions Inc., which makes its core anthrax vaccine in Lansing, has bought the vaccine of a rival company.
http://www.lansingstatejournal.com/apps/pbcs.dll/article?AID=/20080505/NEWS03/805050345

VaxGen Inc. News & Articles on washingtonpost.com

VaxGen Inc. News & Articles on washingtonpost.com. ... More search results for vaxgen Inc. on washingtonpost.com ?. vaxgen Inc. Articles. on the Web ...
http://www.washingtonpost.com/ac2/related/topic/VaxGen+Inc.

Brian Deer on VaxGen's AidsVax - vaccine results

VaxGen Announces Initial Results of its Phase III AIDS Vaccine Trial ... vaxgen intends to conduct additional analyses to confirm if there was a direct ...
http://briandeer.com/vaxgen/aidsvax-release.htm

Brian Deer investigates VaxGen's Aidsvax

THE vaxgen EXPERIMENT Brian Deer investigates an "Aids vaccine" ... Health Organization, and HIV groups everywhere rooted for vaxgen Inc of ...
http://briandeer.com/aidsvax.htm

Q1 2008 Earnings Call Transcript - Seeking Alpha

And more recently on May 1, we announced the acquisition of an advanced recombinant anthrax vaccine candidate, rPA102 from VaxGen. ...
http://seekingalpha.com/article/76147-emergent-biosolutions-inc-q1-2008-earnings-call-transcript?source=homepage_transcripts_sidebar

WilliamHeyward.com

Founder of Quattro Clinical Research QCR, Dr. William Heyward has been in continuous fights against the world??s deadliest communicable diseases for almost three decades now. Born in Atlanta, Georgia USA, he traveled on the world??s remote areas to co
http://echathost.genblogger.com/23067

VaxGen sells experimental vaccine to rival San Jose Mercury News

VaxGen, the South San Francisco company that has been reduced to a shadow of its former self after losing a 877.5 million federal contract to develop an anthrax vaccine, announced today that it has sold the experimental vaccine to its chief rival.
http://www.mercurynews.com/ci_9159012?source=rss

VaxGen, Raven Bio terminate merger agreement ? VentureBeat

Mar 28, 2008 ... See our story about these two South San Francisco, Calif., biotechs in today&39s daily briefing at VentureBeat LifeScience.
http://venturebeat.com/2008/03/28/vaxgen-raven-bio-terminate-merger-agreement/

Pressroom ::: Next Generation Biodefense, Anthrax Vaccine, Smallpox ...

VaxGen, Inc. ...
http://www.vaxgen.com/pressroom/index.html

VaxGen - Wikipedia, the free encyclopedia

VaxGen is a biopharmaceutical company based in the San Francisco Bay Area. AIDSVAX In 1990s vaxgen developed, and began trials of, an AIDS vaccine ...
http://en.wikipedia.org/wiki/VaxGen

Emergent BioSolutions Acquires Anthrax Vaccine Candidate and ... - FDA news subscription

Emergent BioSolutions has acquired a recombinant protective antigen rPA anthrax vaccine product candidate and related technology from VaxGen. ...
http://fdanews.com/newsletter/article?issueId=11563&articleId=106507

VaxGen Terminates Merger Agreement Liquidation May Follow

vaxgen announced the termination of its merger agreement with Raven in a press release issued last Friday. As a result, liquidation may be in the company's future, reported Steve Johnson for the San Jose Mercury News. According to Johnson, vaxgen had
http://www.californiabiotechlaw.com/archives/-biotech-dealmaking-vaxgen-terminates-merger-agreement-liquidation-may-follow.html

VaxGen sells anthrax vaccine rights for up to 10M Silicon Valley/San Jose Business Journal

VaxGen Inc. said late Sunday it sold all assets and rights related to its anthrax vaccine to Emergent BioSolutions Inc. for 2 million and future payments of up to 8 million. EBS
http://www.bizjournals.com/sanjose/stories/2008/05/05/daily5.html?ana=from_rss

VaxGen&39s Sketchy Statistics -- Cohen 2003 227: 1 -- ScienceNOW

When vaxgen announced the results of the first-ever efficacy trial of an AIDS vaccine on 24 February, a few sharp-eyed scientists questioned the statistical ...
http://sciencenow.sciencemag.org/cgi/content/full/2003/227/1

VaxGen, Inc

VaxGen, Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human ... ...
http://www.vaxgen.com/

Pharmaceutical Technology - VaxGen Biopharmaceutical Manufacturing ...

Specification for vaxgen Biopharmaceutical Manufacturing Plant, San Francisco, USA...
http://www.pharmaceutical-technology.com/projects/vaxgen/specs.html

Emergent BioSolutions Acquires Advanced Recombinant Protective ... - InfoBolsa

In 2004, HHS awarded vaxgen an 877 million contract for delivery of 75 million doses of rPA 102. The contract was subsequently terminated by HHS, ...
http://www.infobolsa.es/v2002/Noticias/noticias_titulares2.asp?Fuente=IBNW&FechaNot=20080505&Clasif=C&Numnot=103585

Our Government Inaction

Our Government Inaction There's a great story buried in the Washington Post's Business section. Emergent BioSolutions, nee BioPort, bought out VaxGen's anthrax vaccine candidate that failed to reach FDA approval in 2006. Emergent has paid vaxgen 2 mil
http://armchairgeneralist.typepad.com/my_weblog/2008/05/our-government.html

VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc. PR Newswire via Yahoo! Finance

VaxGen, Inc. , a biopharmaceutical company, announced today it has completed the sale of all assets and rights related to its recombinant protective antigen anthrax vaccine product candidate and related technology to Emergent BioSolutions, Inc.
http://biz.yahoo.com/prnews/080505/aqm066.html?.v=45

AidsVax flops - VaxGen faces questions

Materials gathered by Brian Deer from his investigation for The Sunday Times of London of vaxgen Inc of California, and its "world&39s first Aids vaccine" ...
http://briandeer.com/vaxgen-aidsvax.htm

AidsVax flops - VaxGen faces questions

VaxGen and AidsVax ... The Sunday Times of London of vaxgen Inc of California, and its "world's first ... Heyward, now a vaxgen vice-president, eventually ...
http://briandeer.com/vaxgen-aidsvax.htm

BioPortfolio News : VaxGen to Present at Roth Capital Partners New ...

BioPortfolio News - vaxgen to Present at Roth Capital Partners New York Conference 2005 and BioCentury's NewsMakers in the Biotech Industry
http://www.bioportfolio.com/aug_05/26_08_2005/VaxGen_to_Present_at_Roth.html

VaxGen sells vaccine for anthrax to rival - San Jose Mercury News

VaxGen, the South San Francisco company that has been reduced to a shadow of its former self after losing an 877.5 million federal contract to develop an ...VaxGen Sells Anthrax Vaccine Program and Related Assets and ... FOXBusiness
http://www.mercurynews.com/business/ci_9167617

Bioroundup: Stem-cell science and money, genetic tests go political, clinical-trial data woes, and more

NOTE: Apologies ?? especially to RSS readers ?? if you??ve seen this post before, but an apparent server error ate it late yesterday and I was only able to recover it this morning. Enjoy, or ignore, as seems most fit. Featured stories: Stem-cell s
http://venturebeat.com/2008/01/25/bioroundup-stem-cell-science-and-money-genetic-tests-go-political-clinical-trial-data-woes-and-more/

VaxGen wraps up sale of anthrax assets BizJournals

VaxGen Inc. finished selling the assets of its anthrax vaccine program for 2 million.
http://www.bizjournals.com/sanfrancisco/stories/2008/05/05/daily1.html?ana=from_rss

VaxGen Sells Anthrax Vaccine Program and Related Assets and ...

About vaxgen VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-05-2008/0004805849&EDATE=

investor.vaxgen.com

Vaxgen Press Release
http://investor.vaxgen.com/profiles/investor/ResLibraryView.asp?ResLibraryID=20109&GoTopage=1&BzID=923&Category=214

AidsVax flops - VaxGen faces questions

VaxGen and AidsVax ... ... investigation for The Sunday Times of London of vaxgen Inc of California, and its "world's first Aids vaccine" ...
http://briandeer.com/vaxgen-aidsvax.htm